(Q52647753)

5 May 2018

title

Therapeutic potential of the anti-diabetic agent metformin in targeting the skin cancer stem cell diaspora. (English)

1 reference

5 May 2018

1 reference

neoplastic stem cells

1 reference

1 reference

Anand Reddi

1

1 reference

5 May 2018

Matthew A Powers

series ordinal

2

1 reference

5 May 2018

Robert P Dellavalle

series ordinal

3

1 reference

5 May 2018

publication date

1 May 2014

1 reference

5 May 2018

published in

Experimental Dermatology

1 reference

5 May 2018

volume

23

1 reference

5 May 2018

issue

5

1 reference

5 May 2018

page(s)

345-346

1 reference

5 May 2018

Type 2 diabetes across generations: from pathophysiology to prevention and management

cites work

1 reference

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among U.S. adults with diagnosed diabetes: findings from the 2009 Behavioral Risk Factor Surveillance System

21 January 2018

1 reference

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research

21 January 2018

1 reference

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

21 January 2018

1 reference

Association of metformin use with cancer incidence and mortality: a meta-analysis.

21 January 2018

1 reference

Metformin in dermatology: an overview

21 January 2018

1 reference

Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway

21 January 2018

1 reference

Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation

21 January 2018

1 reference

Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.

21 January 2018

1 reference

Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions

21 January 2018

1 reference

Liver kinase B1 (LKB1) in the pathogenesis of UVB-induced murine basal cell carcinoma

21 January 2018

1 reference

Role of AMPK in UVB-induced DNA damage repair and growth control

21 January 2018

1 reference

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

21 January 2018

1 reference

Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A.

21 January 2018

1 reference

The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis

21 January 2018

1 reference

Cancer stem cells and human malignant melanoma

21 January 2018

1 reference

Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling

21 January 2018

1 reference

Epithelial stem cell mutations that promote squamous cell carcinoma metastasis

21 January 2018

1 reference

Epithelial stem cells, wound healing and cancer

21 January 2018

1 reference

Human skin cancer stem cells: a tale of mice and men.

21 January 2018

1 reference

Putative cancer stem cells in cutaneous malignancies

21 January 2018

1 reference

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

The cancer diaspora: Metastasis beyond the seed and soil hypothesis

21 January 2018

1 reference

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types

21 January 2018

1 reference

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EXD.12349

1 reference

5 May 2018

1 reference

5 May 2018